Introducing Kirsty and Semglee, the Newest Biosimilar Insulin Products Available in Canada – BETTER
INSTRUCTIONS FOR USE SEMGLEE® Single-Patient-Use Prefilled Pen (insulin glargine-yfgn) injection A B C A B C A C D E A B A B C
Semglee - a Cheaper Long-Acting Insulin Option - YouTube
Biocon Launches Biosimilar Semglee
Semglee - a Cheaper Long-Acting Insulin Option - YouTube
These highlights do not include all the information needed to use SEMGLEE safely and effectively. See full prescribing information for SEMGLEE. SEMGLEE® (insulin glargine-yfgn) injection, for subcutaneous use Initial U.S. Approval: 2021SEMGLEE® (